2nd-hand smoke exposure of hospitalized nonsmoker cardiac patients

November 10, 2014

While nonsmoking patients hospitalized with coronary heart disease (CHD) reported secondhand tobacco smoke (SHS) exposure in the days before their hospital admission, only 17.3 percent of patients recalled a physician or nurse asking them about their SHS exposure despite evidence that SHS increases nonsmokers' risk of cardiovascular disease, according to a report published online by JAMA Internal Medicine.

SHS exposure also is associated with a higher likelihood of subsequent cardiovascular and all-cause mortality as well as another heart attack, according to background in the research letter.

Sandra J. Japuntich, Ph.D., of the Veterans Affairs Boston Healthcare System, who conducted the research while at the Massachusetts General Hospital, Boston, and colleagues enrolled 214 patients in a study after they were admitted to a hospital with ischemic CHD and reported no tobacco or nicotine replacement use. Patients were interviewed about their SHS exposure at home, work and in their car, as well as their beliefs about the risks of SHS and any interventions by health care professionals since being admitted to the hospital regarding SHS exposure.

The study results indicate that 47 patients (22 percent) reported SHS in the 30 days before hospital admission and 33 patients (15.4 percent) reported SHS in the seven days before admission. Nearly 14 percent of the patients (n=29) lived with a smoker. Analyses of detectable cotinine found that among 184 individuals with sufficient samples, 15 (8.2 percent) had detectable cotinine (greater than or equal to 0.020 ng/mL) and among 72 saliva samples analyzed with a more sensitive test, 29 (40.3 percent) had detectable cotinine (greater than or equal to 0.05 ng/mL). The also study found that most patients (89.7 percent) believed SHS was harmful to the health of nonsmokers, but only 37 patients (17.3 percent) recalled being asked about their SHS exposure since being admitted to the hospital.
-end-
"The findings of this study make a strong case for the need to address SHS exposure more effectively in inpatient cardiology practice," the research letter concludes.

(JAMA Intern Med. Published online November 10, 2014. doi:10.1001/jamainternmed.2014.5476. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Authors made conflict of interest disclosures. This study was supported by a grant from the Flight Attendant Medical Research Institute and a career development award to an author from the U.S. Department of Veterans Affairs Clinical Sciences Research and Development Service. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Commentary: Learning to Act on 2nd-Hand Smoke Exposure

In a related commentary, R. William Vandivier, M.D., of the University of Colorado, Department of Medicine, Aurora, writes: "This study is important because it clearly demonstrates where the health care community has failed to translate research into action. ... Regardless of the method used to stimulate counseling by health care providers, the present study emphasizes the need to allocate energy and resources to uncover the effects of SHS exposure and learn how to maximally implement these findings in patients to improve their health." (JAMA Intern Med. Published online November 10, 2014. doi:10.1001/jamainternmed.2014.4046. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Media Advisory: To contact corresponding author Nancy A. Rigotti, M.D., call Terri Ogan at 617-726-0954 or email togan@partners.org. To contact commentary author R. William Vandivier, M.D., call Mark Couch at 303-724-5377 or email mark.couch@ucdenver.edu.

The JAMA Network Journals

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.